HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.

Expert Perspectives on Advances in Cervical Cancer Screening

Experts in obstetrics and gynecology share key insights and practical approaches to managing screening and testing strategies for cervical cancer.

This video series was sponsored by Roche Diagnostics.

EP1: Role of HPV Screening and Vaccination for Cervical Cancer

May 13th 2022

Emily K. Hill, MD; Sangini S. Sheth, MD, MPH, FACOG, and Mark. H. Stoler, MD, FASCP, review the rationale of screening for HPV and vaccinating patients to prevent progression to cervical cancer.

EP2: Awareness and Outreach for Cervical Cancer Screening

May 13th 2022

Drs Mark H. Stoler, Emily K. Hill, Sangini S. Sheth, and Thomas C. Wright comment on the general awareness around HPV and cervical cancer in patients as well as the importance of increasing routine cervical cancer screening approaching those conversations with patients.

EP3: HPV and Cervical Cancer Screening Testing Considerations

May 26th 2022

Experts in obstetric and gynecologic management examine conventional cervical cancer screening strategies and consider their specificity and sensitivity targets.

EP4: Current US HPV and Cervical Cancer Screening Guidelines

May 26th 2022

Emily K. Hill, MD, reviews the current US HPV and cervical cancer screening guidelines from the American Cancer Society, American College of Obstetricians and Gynecologists, and the American Society for Colposcopy and Cervical Pathology and discusses the differences within.

EP5: HPV and Cervical Cancer Screening Implementation and Risk Considerations

June 7th 2022

Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler, comment on the implementation considerations surrounding HPV and cervical cancer screening.

EP6: COVID-19 and Cervical Cancer Screening Rates

June 7th 2022

Thomas C. Wright Jr., MD; Emily K Hill, MD; and Sangini S. Sheth, MD, MPH, FACOG, comment on the impact COVID-19 had on HPV and cervical cancer screening in their respective practices.

EP7: Addressing the Impact of HPV Vaccination Uptake on Cervical Cancer Screening

June 15th 2022

Drs Sangini S. Sheth and Mark H. Stoler share their thoughts on the adoption of primary HPV screening and how they foresee changes to cervical cancer screening as more individuals get vaccinated.

EP8: Role of Dual Testing in HPV Positive Triage Management

June 15th 2022

Mark H. Stoler, MD, FASCP, provides insight on the role of dual testing in the management of HPV positive women.

EP9: Role of HPV Genotypes in Cervical Cancer

June 22nd 2022

Experts in obstetric and gynecologic management provide insight on the role of HPV genotypes in cervical cancer risk.

EP10: Key Takeaways for HPV and Cervical Cancer Screening

June 22nd 2022

Drs Emily K. Hill, Sangini S. Sheth, and Mark H. Stoler share practice pearls for HPV and cervical cancer screening and express their hope for emerging testing options.